SCALAMBRA, LAURA
 Distribuzione geografica
Continente #
AS - Asia 1.159
NA - Nord America 862
EU - Europa 819
Continente sconosciuto - Info sul continente non disponibili 84
AF - Africa 60
SA - Sud America 44
OC - Oceania 1
Totale 3.029
Nazione #
US - Stati Uniti d'America 825
IT - Italia 501
CN - Cina 442
VN - Vietnam 261
SG - Singapore 225
NL - Olanda 69
DE - Germania 64
HK - Hong Kong 55
KR - Corea 54
IN - India 35
FR - Francia 30
BR - Brasile 29
BD - Bangladesh 24
GB - Regno Unito 24
CI - Costa d'Avorio 23
SE - Svezia 23
CA - Canada 22
FI - Finlandia 21
JP - Giappone 15
IE - Irlanda 14
ZA - Sudafrica 14
AT - Austria 13
CH - Svizzera 13
RU - Federazione Russa 11
IQ - Iraq 8
BG - Bulgaria 7
SC - Seychelles 7
AR - Argentina 6
TH - Thailandia 6
UA - Ucraina 6
DK - Danimarca 5
ID - Indonesia 5
EC - Ecuador 4
JO - Giordania 4
MX - Messico 4
PH - Filippine 4
TG - Togo 4
TW - Taiwan 4
DZ - Algeria 3
EG - Egitto 3
JM - Giamaica 3
LT - Lituania 3
PK - Pakistan 3
TR - Turchia 3
VE - Venezuela 3
HR - Croazia 2
IR - Iran 2
LI - Liechtenstein 2
MA - Marocco 2
MY - Malesia 2
PL - Polonia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BB - Barbados 1
BE - Belgio 1
BJ - Benin 1
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ES - Italia 1
GE - Georgia 1
GI - Gibilterra 1
GP - Guadalupe 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
LV - Lettonia 1
MN - Mongolia 1
MQ - Martinica 1
MU - Mauritius 1
NI - Nicaragua 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TN - Tunisia 1
Totale 2.945
Città #
Singapore 171
Shanghai 170
Bologna 144
Hefei 122
Ashburn 93
San Jose 83
Ho Chi Minh City 74
Hanoi 63
Council Bluffs 59
Hong Kong 52
Seoul 52
Milan 33
Los Angeles 30
Chandler 29
Dallas 25
New York 24
Santa Clara 24
Abidjan 23
Houston 22
Fairfield 21
Boardman 20
Beijing 19
Casalecchio di Reno 19
Chicago 17
Dublin 14
Woodbridge 13
Ann Arbor 12
Lauterbourg 12
Vienna 12
Frankfurt am Main 11
Johannesburg 11
Rimini 11
Bengaluru 10
Bern 10
Da Nang 10
Lappeenranta 10
Tokyo 10
Turin 10
Amsterdam 9
Cambridge 9
Haiphong 9
Seattle 9
Falkenstein 8
Princeton 8
Southend 8
Bremen 7
Buffalo 7
Kerpen 7
Miami 7
Naples 7
Porto Recanati 7
Rome 7
Sofia 7
Vicenza 7
Delhi 6
Helsinki 6
Kyiv 6
Parma 6
Phoenix 6
Redmond 6
São Paulo 6
Biên Hòa 5
Bo 5
Bến Tre 5
Montreal 5
The Dalles 5
Turku 5
Wilmington 5
Amman 4
Baghdad 4
Bangkok 4
Bluffdale 4
Bắc Giang 4
Can Tho 4
Cimitile 4
Galliera 4
Guangzhou 4
Hayward 4
Jacksonville 4
Jakarta 4
Lomé 4
Long Xuyen 4
Mansfield 4
Munich 4
Padua 4
Reggio Nell'emilia 4
Thái Nguyên 4
Tongling 4
Wangen 4
Algiers 3
Botticino 3
Boydton 3
Castenaso 3
Cento 3
Florence 3
Guayaquil 3
London 3
Mumbai 3
Nanjing 3
Nærum 3
Totale 1.862
Nome #
IFN-γ and CD38 in Hyperprogressive Cancer Development 456
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft 352
PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD) 275
Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma 240
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression 234
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC 228
Functional evaluation of circulating anti-cancer antibodies with a 3D tumor cell growth inhibition assay 224
Lipid rafts, caveolae, and epidermal growth factor receptor family: friends or foes? 216
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy 199
Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine 192
Preclinical activity of ES2B-C001, a human candidate HER-2 virus-like particle (VLP) vaccine, against mammary carcinoma onset and metastasis 161
Development of cellular models expressing cynomolgus (Macaca fascicularis) HER2 for the functional evaluation of cross-reactive anti-human HER2 response 99
Alternatives for fetal bovine serum (FBS) and sustainability of milk derivatives in cell culture 57
Requalified bovine milk as a sustainable supplement for cell cultures 56
HER-2 therapeutic vaccine is not hampered by concurrent HER-2 monoclonal antibody 40
Totale 3.029
Categoria #
all - tutte 7.318
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.318


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202298 0 0 0 8 19 21 4 4 11 9 15 7
2022/2023174 7 11 7 22 15 18 13 8 27 8 19 19
2023/2024295 10 4 22 21 17 15 9 176 4 10 2 5
2024/2025589 18 64 37 22 61 24 71 42 7 78 52 113
2025/20261.362 121 234 109 118 88 59 98 34 235 99 75 92
2026/2027341 54 91 103 93 0 0 0 0 0 0 0 0
Totale 3.029